In a study on metabolic dysfunction-associated steatotic liver disease (MASLD), the new definition of NAFLD, organoid models exhibited varying cellular responses under different induction conditions (oleic acid, palmitic acid, and transforming growth factor beta 1 (TGF-β1). This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.